Amdipharm Mercury, Concordia Healthcare deal

Concordia completed its acquisition of fellow generic and pharmaceutical company Amdipharm from private equity firm

Read the full 153 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE